Literature DB >> 21757831

IgG4-related skin lesions in a patient with IgG4-related chronic sclerosing dacryoadenitis and sialoadenitis.

Yasushi Kakuchi1, Kazunori Yamada, Yasunori Suzuki, Naoko Ito, Kunimasa Yagi, Masami Matsumura, Masakazu Yamagishi, Hisanori Umehara, Yoh Zen, Minoru Hasegawa, Kazuhiko Takehara, Mitsuhiro Kawano.   

Abstract

We describe a 60-year-old man with IgG4-related chronic sclerosing dacryoadenitis and sialoadenitis associated with lymphoplasmacytic and eosinophilic infiltration in erythematous nodules. Physical examination revealed left eye extrusion and small itchy nodules on the scalp and neck. The serum IgG level was 1,570 mg/dL, IgG4 463 mg/dL (29.5%), and IgE 4,554 IU/mL. Lacrimal gland biopsy disclosed prominent infiltrates of IgG4-positive plasma cells and scattered eosinophilic infiltrates with fibrosis, consistent with IgG4-related disease. A skin biopsy of a cutaneous nodule demonstrated that the infiltrated plasma cells around arterioles or venules in the deep dermis and subcutaneous fat tissue were strongly positive for IgG4. Although the swollen lacrimal and parotid gland and itchy subcutaneous erythematous nodules improved rapidly with oral prednisolone at a dose of 20 mg per day, the skin, lacrimal, and parotid lesions deteriorated simultaneously during steroid tapering and improved after increasing the dosage. As skin lesions are easy to biopsy, further study of the skin manifestations of IgG4-related disease will be important in further clarifying the clinical spectrum, pathophysiology and response to therapy of this disorder.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21757831     DOI: 10.2169/internalmedicine.50.5239

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  1 in total

1.  IgG4-related Skin Lesion with Mikulicz's Disease.

Authors:  Hidetoshi Takahashi; Masako Hori; Naoyuki Miyokawa; Hajime Iizuka
Journal:  Indian J Dermatol       Date:  2016 Jan-Feb       Impact factor: 1.494

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.